Articles Archives - Page 281 of 715

MondayMar 28, 2022 9:00 am

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

Novel drug development company Mydecine Innovations Group is focusing on a medicinal pipeline for psychedelic drug candidates that have established some efficacy in treating mental illnesses — specifically addiction Mydecine is progressing in its clinical trial evaluation of its lead candidate, MYCO-001, and is finalizing an IND application with the FDA to begin patient dosing for its planned Phase 2 trials The company is targeting nicotine addiction in tobacco smokers Mydecine is also advancing its evaluation of other drug candidates with pending patents to enhance its existing products Medical-use psychedelic drug product developer Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF)…

FridayMar 25, 2022 2:30 pm

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

Fintech, Healthcare, pharma, technology, finance, infrastructure, and allied companies and investors are invited to attend the Virtual Growth Conference, being held on March 28-30, 2022, as a virtual event. The year 2022 opens up opportunities for traders and investors and this Virtual Growth Conference 2022 offers the perfect stage for networking and understanding the future scope of business. The Virtual Growth Conference is one of the leading investor conferences, organized by M-Vest Events, powered by the Maxim Group LLC, a leading investment bank. The group serves investors, issuers and industry stalwarts, allowing them to interact on an excellent online forum.…

FridayMar 25, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia

Cannabis product cultivator Flora Growth Corp. operates a premium growing facility in central Colombia and has received a growing list of authorizations to export its cannabis products for varied health and wellness purposes Flora Growth’s authorized distribution of low-THC CBD cannabis derivatives has been recently expanded to include a quota of up to 43,600 kg of products with high-THC cannabis Flora also reached agreement with Israel-based DNO Group to further commercialize Flora’s Mind Naturals skin care products through potential distribution outlets in Hong Kong, with plans to build into outlets in Israel and India later Colombia has also authorized the…

FridayMar 25, 2022 9:15 am

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Anticipates Growth in Value Given the Continued Rise in Inflation

The inflation rate in the United States for the 12 months ending February 2022 was 7.9%, the highest it has been since January 1982 In addition to the rise in inflation, the price of gold has risen to levels not previously seen StraightUp Resources Inc. looks to capitalize on this growing price and looks to benefit from it given its investments in properties with a rich history of gold production Although today there are a number of investments being touted as the best hedges against inflation, the current high rate of inflation, and its long-term prospects for continuing, together with…

FridayMar 25, 2022 9:15 am

SPYR Inc. (SPYR) Appoints Michael Teitelbaum and Siobhán Ellis to Subsidiary Applied Magix Inc. Advisory Board

Both additions to the advisory board will aid SPYR’s continued effort to identify and target acquisitions to grow in the industry and expand its product offering to consumers Mr. Teitelbaum’s experience as the senior board integrity manager of Jazzwares will help him leverage the resources necessary to facilitate growth and grow the brand Ms. Ellis is an avid HomeKit user and has experience working with data in her current role at the U.K. offices of Jaguar Land Rover Technology company SPYR (OTCQB: SPYR), dba SPYR Technologies, and its subsidiary Applied Magix Inc., which develops and resells Apple(R) compatible products for…

FridayMar 25, 2022 9:15 am

SRAX Inc. (NASDAQ: SRAX) Seeks to Become the Information Venue of Choice for Today’s Retail Investor Community

Retail investment has boomed of late, with retail investors accounting for 23% of all U.S. equity market transactions in 2021 SRAX and investor intelligence platform, Sequire, have sought to service the informational needs of a burgeoning investor community, which now numbers over 9 million Sequire has looked to add value through a series of investor masterclasses and a community investor newsletter, as well as an array of corporate access events focusing on all segments of the stock market SRAX and Sequire sought to bolster their investment offering through the acquisition of leading small and mid-cap stock specialist, LD Micro, in…

FridayMar 25, 2022 9:00 am

Interactive Session on Psychedelics for Alcoholism, Q&A with Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Management

Clearmind (CSE: CMND) (FSE: CWY0) Management invites leaders, innovators, scientists, doctors, patients, enthusiasts, and luminaries in the psychedelic space to attend a virtual Q&A session on March 30th, focused on the potential treatment of alcohol use and binge drinking based on its psychoactive molecule MEAI. Global leaders and innovators in the psychedelic space will participate in the virtual event and discuss psychedelic therapies and treatments for excessive alcohol consumption and mental disorders. The dedicated team of experts at Clearmind is engaged in developing breakthrough treatments for binge behaviour, alcohol use disorder, binge eating and depression. Adi Zuloff-Shani, PhD, Clearmind’s Chief…

FridayMar 25, 2022 9:00 am

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic

Following the acquisition of KWC back in November 2021, Delic Holdings Corp set out to open additional state-of-the-art ketamine infusion treatment clinics over the course of 18 months The company has just announced the opening of its second clinic in Nevada in a move that will serve both local patients and those in larger California markets without access to affordable in-state providers Delic is still set to open more clinics over the course of the next 18 months in a move that seeks to expand access to reasonably priced treatments for various mental health conditions In November 2021, Delic Holdings…

ThursdayMar 24, 2022 9:15 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Focusing on Profitability and Growth of Its Verticals in 2022

PlantX is the digital face of the plant-based community whose verticals operate across three main categories: products, distribution and community The company is leveraging a robust e-commerce ecosystem to link consumers to over 5,000 plant-based products By opening new locations for its XMarket brick and mortar stores, the company has strengthened its distribution capabilities PlantX also offers educational resources as well as fitness solutions Moving forward, the company has locked its sights on profitability, building on the growth witnessed in its most recent quarter Created as a plant-based lifestyle brand, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has always…

ThursdayMar 24, 2022 9:15 am

Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Is a Leader in Psychedelic-Based Therapies; Recent Preclinical Research Shows Treatment Effective for MDD

Study shows that substantial antidepressant effects of psilocybin-based treatment, given with supportive psychotherapy, may last at least a year. Psilocybin could lead to significant, durable improvements in depression. Cybin is focused on improving overall mental health through psychedelic-based therapies. Johns Hopkins Medicine researchers have released a report noting that psilocybin treatment for major depression is effective for up to a year for many patients (https://ibn.fm/ZF8jH). That bodes well for Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company that is focused on revolutionizing mental health care, including major depressive disorder (“MDD”). “Previous studies by Johns Hopkins Medicine researchers…

Site Search

Company Search

Category: Articles

Psychedelic Medicine Researcher Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Readies IND Application to Advance Drug Trials

The Virtual Growth Conference By M-Vest Events to Offer a Powerful Networking Stage

Flora Growth Corp. (NASDAQ: FLGC) Reaches Agreements Green-Lighting High-THC Cannabis Exports from Colombia, and Outlets for Premium CBD Skin Care Product in Asia

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Anticipates Growth in Value Given the Continued Rise in Inflation

SPYR Inc. (SPYR) Appoints Michael Teitelbaum and Siobhán Ellis to Subsidiary Applied Magix Inc. Advisory Board

SRAX Inc. (NASDAQ: SRAX) Seeks to Become the Information Venue of Choice for Today’s Retail Investor Community

Interactive Session on Psychedelics for Alcoholism, Q&A with Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Management

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Makes Psychedelic Treatment More Accessible with Opening of New Reno Clinic

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Focusing on Profitability and Growth of Its Verticals in 2022

Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Is a Leader in Psychedelic-Based Therapies; Recent Preclinical Research Shows Treatment Effective for MDD

Market Basics

Newsletter Publishers

Public Companies